Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Susan Refice"'
Autor:
Jacqueline Gunther, Mirella L. Altoe, Richard Ha, Hyun K. Kim, Kevin Kalinsky, Andreas H. Hielscher, Molly Lara Flexman, Hanina Hibshoosh, Dawn L. Hershman, Emerson A. Lim, Mindy Brown, Susan Refice
Publikováno v:
Biophotonics Congress: Biomedical Optics Congress 2018 (Microscopy/Translational/Brain/OTS).
In a clinical pilot study involving patients undergoing neoadjuvant chemotherapy, we explored evidence that diffuse optical tomography can be used to monitor tumor progression and predict treatment response.
Autor:
Jacqueline Gunther, Emerson A. Lim, Kevin Kalinsky, Dawn L. Hershman, Molly Lara Flexman, Mindy Brown, Andreas H. Hielscher, Mirella L. Altoe, Susan Refice, Hyun K. Kim
Publikováno v:
Biomedical Optics 2016.
In a clinical pilot study involving patients undergoing neoadjuvant chemotherapy, we explored evidence that diffuse optical tomography can be used to monitor tumor progression and predict treatment response.
Autor:
Matthew A. Maurer, Lois Brafman, Sheldon Feldman, Kd. Crew, Dawn L. Hershman, Kevin Kalinsky, Susan Refice
Publikováno v:
Cancer Research. 70:P1-07
Background: Vitamin D has diverse biological effects on proliferation, differentiation, and apoptosis in multiple tissues, including the breast. Observational studies have demonstrated that serum 25-hydroxyvitamin D (25-OHD), an objective measure of
Autor:
Dawn L. Hershman, Hyun K. Kim, Emerson A. Lim, Kevin Kalinsky, Lukas Zweck, Sindhiya Arora, Jacqueline Gunther, Mindy Brown, Susan Refice, Andreas H. Hielscher, Molly Lara Flexman
Publikováno v:
Diffuse Optical Imaging V.
We explored evidence that a combination of dynamic and static diffuse optical tomography can be used to predict treatment response in patients undergoing neoadjuvant chemotherapy. Both blood chromophore concentrations and hemodynamic signatures were
Autor:
Kevin Kalinsky, Jacqueline Gunther, Mindy Brown, Hyun K. Kim, Susan Refice, Andreas H. Hielscher, Dawn L. Hershman, Emerson A. Lim
Publikováno v:
Optical Tomography and Spectroscopy of Tissue XI.
We have developed a dynamic diffuse optical tomography imaging system that is capable of 3D imaging of both breasts simultaneously. In an ongoing study subjects receiving neoadjuvant chemotherapy are imaged at 6 time points throughout their 5-month t
Autor:
Antai Wang, Sheldon Feldman, Tong Xiao, Matthew Maurer, Serge Cremers, Aqeel Ahmad, Kevin Kalinsky, Susan Refice, Katherine D. Crew, Dawn L. Hershman, Hanina Hibshoosh, Bret Taback
Publikováno v:
Cancer investigation. 32(4)
Introduction: We conducted a presurgical trial to assess the tissue-related effects of metformin in overweight/obese breast cancer (BC) patients. Methods: Metformin 1,500 mg daily was administered to 35 nondiabetics with stage 0–III BC, body mass i
Autor:
Susan Refice, Hyun K. Kim, Emerson A. Lim, Dawn L. Hershman, Melinda Brown, Jacqueline Gunther, Molly Lara Flexman, Kevin Kalinsky, Andreas H. Hielscher
Publikováno v:
Biomedical Optics 2014.
In a clinical pilot study we explored evidence that dynamic diffuse optical tomography can be used to predict treatment response in patients undergoing neoadjuvant chemotherapy.
Autor:
Jacqueline Gunther, Susan Refice, Emerson A. Lim, Andreas H. Hielscher, Hyun K. Kim, Dawn L. Hershman, Mindy Brown, Kevin Kalinsky, Molly Lara Flexman
Publikováno v:
SPIE Proceedings.
We have developed a diffuse optical tomography imaging system to track breast tumor progression in patients undergoing neoadjuvant chemotherapy. Preliminary results have shown that tumor response can be predicted by the second week of treatment.
Autor:
Kevin Kalinsky, Susan Refice, Emerson A. Lim, Bret Taback, Molly Lara Flexman, Matthew Maurer, Andreas H. Hielscher, Hyun K. Kim, Katherine D. Crew, Sheldon Feldman, Jacqueline Gunther, Dawn L. Hershman, Hanina Hibshoosh, Margaret Chen, Preya Ananthakrishnan
Publikováno v:
Cancer Research. 75:P5-01
Background: The Residual Cancer Burden (RCB) score predicts survival in patients (pts) with breast cancer (BC) treated with neoadjuvant chemotherapy (NACT). Predicting tumor response early during NACT may allow for treatment optimization. Diffuse opt